Staphylococcus aureus vaccines: Deviating from the carol

Journal of Experimental Medicine

Volumn 213, Issue 9, 2016, Pages 1645-1653

  Missiakas, Dominique ^a   Schneewind, Olaf ^a  

^a UNIVERSITY OF CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

B CELL SUPERANTIGEN; B LYMPHOCYTE ANTIGEN; COAGULASE; FIBRIN; POLYSACCHARIDE VACCINE; PROTEIN A; STAPHYLOCOCCUS VACCINE; SUBUNIT VACCINE; SUPERANTIGEN; UNCLASSIFIED DRUG; VACCINE;

ANTIGEN FUNCTION; ARTICLE; BACTEREMIA; BACTERIAL COLONIZATION; BACTERIAL GENOME; BACTERIAL IMMUNITY; CLINICAL TRIAL (TOPIC); COMMENSALISM; DRUG EFFICACY; GENOMICS; HEMOSTASIS; HOST; HUMAN; IMMUNE EVASION; INFECTION RISK; NONHUMAN; OPSONIZATION; PHAGOCYTE; PHAGOCYTOSIS; PHASE 2 CLINICAL TRIAL (TOPIC); PRIORITY JOURNAL; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS INFECTION; SURGICAL INFECTION; VACCINATION; VACCINE PRODUCTION; HOMEOSTASIS; IMMUNOLOGY; METHODOLOGY; SURGICAL WOUND INFECTION;

BACTEREMIA; CLINICAL TRIALS AS TOPIC; HOMEOSTASIS; HUMANS; PHAGOCYTOSIS; RESEARCH DESIGN; STAPHYLOCOCCAL VACCINES; STAPHYLOCOCCUS AUREUS; SURGICAL WOUND INFECTION; VACCINES, CONJUGATE; VACCINES, SUBUNIT;

EID: 84984818533     PISSN: 00221007     EISSN: 15409538     Source Type: Journal    
DOI: 10.1084/jem.20160569     Document Type: Article

References (81)

1. Anderson, A.S., A.A. Miller, R.G.K. Donald, I.L. Scully, J.S. Nanra, D. Cooper, and K.U. Jansen. 2012. Development of a multicomponent Staphylococcus aureus vaccine designed to counter multiple bacterial virulence factors. Hum. Vaccin. Immunother. 8:1585-1594. http://dx.doi.org/10.4161/hv.21872
2. Auranen, K., H. Rinta-Kokko, D. Goldblatt, H. Nohynek, K.L. O'Brien, C. Satzke, B. Simell, A. Tanskanen, and H. Käyhty. Pneumococcal Carriage Group (PneumoCarr). 2013. Colonisation endpoints in Streptococcus pneumoniae vaccine trials. Vaccine. 32:153-158. http://dx.doi.org/10.1016/j.vaccine.2013.08.061
3. Avery, O.T., and W.F. Goebel. 1929. Chemical-immunological studies on conjugated carbohydrate-proteins. II. Immunological specificity of synthetic sugar-protein antigens. J. Exp. Med. 50:533-550. http://dx.doi.org/10.1084/jem.50.4.533
4. Behring, E.A. 1890. Über das Zustandekommen der Diphtherie-Immunität bei Thieren. Dtsch. Med. Wochenschr. 16:1145-1148. http://dx.doi.org/10.1055/s -0029-1207609
5. Black, S.B., H.R. Shinefield, B. Fireman, R. Hiatt, M. Polen, and E. Vittinghoff. The Northern California Kaiser Permanente Vaccine Study Center Pediatrics Group. 1991. Efficacy in infancy of oligosaccharide conjugate Haemophilus influenzae type b (HbOC) vaccine in a United States population of 61,080 children. Pediatr. Infect. Dis. J. 10:97-104. http://dx.doi.org/10.1097/00006454-199102000-00004
6. Black, S., H. Shinefield, B. Fireman, E. Lewis, P. Ray, J.R. Hansen, L. Elvin, K.M. Ensor, J. Hackell, G. Siber, et al. Northern California Kaiser Permanente Vaccine Study Center Group. 2000. Efficacy, safety and immunogenicity of heptavalent pneumococcal conjugate vaccine in children. Pediatr. Infect. Dis. J. 19:187-195. http://dx.doi.org/10.1097/00006454-200003000-00003
7. Boyle-Vavra, S., X. Li, M.T. Alam, T.D. Read, J. Sieth, C. Cywes-Bentley, G. Dobbins, M.Z. David, N. Kumar, S.J. Eells, et al. 2015. USA300 and USA500 clonal lineages of Staphylococcus aureus do not produce a capsular polysaccharide due to conserved mutations in the cap5 locus. MBio. 6:e02585-14. http://dx.doi.org/10.1128/mBio.02585-14
8. Brown, M., R. Kowalski, J. Zorman, X.M. Wang, V. Towne, Q. Zhao, S. Secore, A.C. Finnefrock, T. Ebert, G. Pancari, et al. 2009. Selection and characterization of murine monoclonal antibodies to Staphylococcus aureus iron-regulated surface determinant B with functional activity in vitro and in vivo. Clin. Vaccine Immunol. 16:1095-1104. http://dx.doi.org/10.1128/CVI.00085-09
9. Chambers, H.F., and F.R. DeLeo. 2009. Waves of resistance: Staphylococcus aureus in the antibiotic era. Nat. Rev. Microbiol. 7:629-641. http://dx.doi.org/10.1038/nrmicro2200
10. Cheng, A.G., M. McAdow, H.K. Kim, T. Bae, D.M. Missiakas, and O. Schneewind. 2010. Contribution of coagulases towards Staphylococcus aureus disease and protective immunity. PLoS Pathog. 6:e1001036. http://dx.doi.org/10.1371/journal.ppat.1001036
11. Cheng, A.G., A.C. DeDent, O. Schneewind, and D. Missiakas. 2011. A play in four acts: Staphylococcus aureus abscess formation. Trends Microbiol.19:225-232. http://dx.doi.org/10.1016/j.tim.2011.01.007
12. Cherry, J.D. 1996. Historical review of pertussis and the classical vaccine. J. Infect. Dis. 174:S259-S263. http://dx.doi.org/10.1093/infdis/174.Supplement _3.S259
13. Clauditz, A., A. Resch, K.P. Wieland, A. Peschel, and F. Götz. 2006. Staphyloxanthin plays a role in the fitness of Staphylococcus aureus and its ability to cope with oxidative stress. Infect. Immun. 74:4950-4953. http://dx.doi.org/10.1128/IAI.00204-06
14. Cole, A.L., G. Muthukrishnan, C. Chong, A. Beavis, C.R. Eade, M.P. Wood, M.G. Deichen, and A.M. Cole. 2016. Host innate inflammatory factors and staphylococcal protein A influence the duration of human Staphylococcus aureus nasal carriage. Mucosal Immunol. http://dx.doi.org/10.1038/mi.2016.2
15. Collier, R.J. 2001. Understanding the mode of action of diphtheria toxin: a perspective on progress during the 20th century. Toxicon. 39:1793-1803. http://dx.doi.org/10.1016/S0041-0101(01)00165-9
16. Creech, C.B. II, B.G. Johnson, A.R. Alsentzer, M. Hohenboken, K.M. Edwards, and T.R. Talbot III. 2009. Vaccination as infection control: a pilot study to determine the impact of Staphylococcus aureus vaccination on nasal carriage. Vaccine. 28:256-260. http://dx.doi.org/10.1016/j.vaccine.2009.09.088
17. Creech, C.B., D.N. Al-Zubeidi, and S.A. Fritz. 2015. Prevention of recurrent staphylococcal skin infections. Infect. Dis. Clin. North Am. 29:429-464. http://dx.doi.org/10.1016/j.idc.2015.05.007
18. Crossley, K., and J. Solliday. 1980. Comparison of rectal swabs and stool cultures for the detection of gastrointestinal carriage of Staphylococcus aureus. J. Clin. Microbiol. 11:433-434.
19. Ellis, M.W., C.D. Schlett, E.V. Millar, K.J. Wilkins, K.B. Crawford, S.M. Morrison-Rodriguez, L.A. Pacha, R.J. Gorwitz, J.B. Lanier, and D.R. Tribble. 2014. Hygiene strategies to prevent methicillin-resistant Staphylococcus aureus skin and soft tissue infections: a clusterrandomized controlled trial among high-risk military trainees. Clin. Infect. Dis. 58:1540-1548. http://dx.doi.org/10.1093/cid/ciu166
20. Etz, H., D.B. Minh, T. Henics, A. Dryla, B. Winkler, C. Triska, A.P. Boyd, J. Söllner, W. Schmidt, U. von Ahsen, et al. 2002. Identification of in vivo expressed vaccine candidate antigens from Staphylococcus aureus. Proc. Natl. Acad. Sci. USA. 99:6573-6578. http://dx.doi.org/10.1073/pnas.092569199
21. Falugi, F., H.K. Kim, D.M. Missiakas, and O. Schneewind. 2013. Role of protein A in the evasion of host adaptive immune responses by Staphylococcus aureus. MBio. 4:e00575-13. http://dx.doi.org/10.1128/mBio.00575-13
22. Fattom, A., R. Schneerson, S.C. Szu, W.F. Vann, J. Shiloach, W.W. Karakawa, and J.B. Robbins. 1990. Synthesis and immunologic properties in mice of vaccines composed of Staphylococcus aureus type 5 and type 8 capsular polysaccharides conjugated to Pseudomonas aeruginosa exotoxin A. Infect. Immun. 58:2367-2374.
23. Fattom, A.I., G. Horwith, S. Fuller, M. Propst, and R. Naso. 2004. Development of StaphVAX, a polysaccharide conjugate vaccine against S. aureus infection: from the lab bench to phase III clinical trials. Vaccine.22:880-887. http://dx.doi.org/10.1016/j.vaccine.2003.11.034
24. Forsgren, A., and P.G. Quie. 1974. Effects of staphylococcal protein A on heat labile opsonins. J. Immunol. 112:1177-1180.
25. Forsgren, A., A. Svedjelund, and H. Wigzell. 1976. Lymphocyte stimulation by protein A of Staphylococcus aureus. Eur. J. Immunol. 6:207-213. http://dx.doi.org/10.1002/eji.1830060312
26. Fowler, V.G. Jr., L.K. Kong, G.R. Corey, G.S. Gottlieb, R.S. McClelland, D.J. Sexton, D. Gesty-Palmer, and L.J. Harrell. 1999. Recurrent Staphylococcus aureus bacteremia: pulsed-field gel electrophoresis findings in 29 patients. J. Infect. Dis. 179:1157-1161. http://dx.doi.org/10.1086/314712
27. Fowler, V.G., K.B. Allen, E.D. Moreira, M. Moustafa, F. Isgro, H.W. Boucher, G.R. Corey, Y. Carmeli, R. Betts, J.S. Hartzel, et al. 2013. Effect of an investigational vaccine for preventing Staphylococcus aureus infections after cardiothoracic surgery: a randomized trial. JAMA. 309:1368-1378.http://dx.doi.org/10.1001/jama.2013.3010.
28. Frasch, C.E. 2005. Recent developments in Neisseria meningitidis group A conjugate vaccines. Expert Opin. Biol. Ther. 5:273-280. http://dx.doi.org/10.1517/14712598.5.2.273
29. Friedrich, R., P. Panizzi, P. Fuentes-Prior, K. Richter, I. Verhamme, P.J. Anderson, S. Kawabata, R. Huber, W. Bode, and P.E. Bock. 2003. Staphylocoagulase is a prototype for the mechanism of cofactor-induced zymogen activation. Nature. 425:535-539. http://dx.doi.org/10.1038/nature01962
30. Geno, K.A., G.L. Gilbert, J.Y. Song, I.C. Skovsted, K.P. Klugman, C. Jones, H.B. Konradsen, and M.H. Nahm. 2015. Pneumococcal capsules and their types: past, present, and future. Clin. Microbiol. Rev. 28:871-899. http://dx.doi.org/10.1128/CMR.00024-15
31. Glenny, A.T., G.A.H. Buttle, and M.F. Stevens. 1931. Rate of disappearance of diphtheria toxoid injected into rabbits and guinea-pigs: toxoid precipitated with alum. J. Pathol. Bacteriol. 34:267-275. http://dx.doi.org/10.1002/path.1700340214
32. Goldschneider, I., E.C. Gotschlich, and M.S. Artenstein. 1969. Human immunity to the meningococcus. I. The role of humoral antibodies. J. Exp. Med. 129:1307-1326. http://dx.doi.org/10.1084/jem.129.6.1307
33. Gorwitz, R.J., D. Kruszon-Moran, S.K. McAllister, G. McQuillan, L.K. McDougal, G.E. Fosheim, B.J. Jensen, G. Killgore, F.C. Tenover, and M.J. Kuehnert. 2008. Changes in the prevalence of nasal colonization with Staphylococcus aureus in the United States, 2001-2004. J. Infect. Dis.197:1226-1234. http://dx.doi.org/10.1086/533494
34. Guggenberger, C., C. Wolz, J.A. Morrissey, and J. Heesemann. 2012. Two distinct coagulase-dependent barriers protect Staphylococcus aureus from neutrophils in a three dimensional in vitro infection model. PLoS Pathog. 8:e1002434. http://dx.doi.org/10.1371/journal.ppat.1002434
35. Heidelberger, M., and O.T. Avery. 1923. The soluble specific substance of pneumococcus. J. Exp. Med. 38:73-79. http://dx.doi.org/10.1084/jem.38.1.73
36. Hersh, A.L., H.F. Chambers, J.H. Maselli, and R. Gonzales. 2008. National trends in ambulatory visits and antibiotic prescribing for skin and softtissue infections. Arch. Intern. Med. 168:1585-1591. http://dx.doi.org/10.1001/archinte.168.14.1585
37. Holt, D.C., M.T. Holden, S.Y. Tong, S. Castillo-Ramirez, L. Clarke, M.A. Quail, B.J. Currie, J. Parkhill, S.D. Bentley, E.J. Feil, and P.M. Giffard. 2011. A very early-branching Staphylococcus aureus lineage lacking the carotenoid pigment staphyloxanthin. Genome Biol. Evol. 3:881-895. http://dx.doi.org/10.1093/gbe/evr078
38. Ito, T., Y. Katayama, K. Asada, N. Mori, K. Tsutsumimoto, C. Tiensasitorn, and K. Hiramatsu. 2001. Structural comparison of three types of staphylococcal cassette chromosome mec integrated in the chromosome in methicillin-resistant Staphylococcus aureus. Antimicrob. Agents Chemother. 45:1323-1336. http://dx.doi.org/10.1128/AAC.45.5.1323-1336.2001
39. Kim, H.K., A.G. Cheng, H.-Y. Kim, D.M. Missiakas, and O. Schneewind. 2010a. Nontoxigenic protein A vaccine for methicillin-resistant Staphylococcus aureus infections in mice. J. Exp. Med. 207:1863-1870. http://dx.doi.org/10.1084/jem.20092514
40. Kim, H.K., A. DeDent, A.G. Cheng, M. McAdow, F. Bagnoli, D.M. Missiakas, and O. Schneewind. 2010b. IsdA and IsdB antibodies protect mice against Staphylococcus aureus abscess formation and lethal challenge. Vaccine. 28:6382-6392. http://dx.doi.org/10.1016/j.vaccine.2010.02.097
41. Kim, H.K., V. Thammavongsa, O. Schneewind, and D. Missiakas. 2012. Recurrent infections and immune evasion strategies of Staphylococcus aureus. Curr. Opin. Microbiol. 15:92-99. http://dx.doi.org/10.1016/j.mib.2011.10.012
42. Kim, H.K., F. Falugi, D.M. Missiakas, and O. Schneewind. 2016. Peptidoglycanlinked protein A promotes T cell-dependent antibody expansion during Staphylococcus aureus infection. Proc. Natl. Acad. Sci. USA. 113:5718-5723. http://dx.doi.org/10.1073/pnas.1524267113
43. Kroh, H.K., P. Panizzi, and P.E. Bock. 2009. Von Willebrand factor-binding protein is a hysteretic conformational activator of prothrombin. Proc. Natl. Acad. Sci. USA. 106:7786-7791. http://dx.doi.org/10.1073/pnas.0811750106
44. Kuklin, N.A., D.J. Clark, S. Secore, J. Cook, L.D. Cope, T. McNeely, L. Noble, M.J. Brown, J.K. Zorman, X.M. Wang, et al. 2006. A novel Staphylococcus aureus vaccine: iron surface determinant B induces rapid antibody responses in rhesus macaques and specific increased survival in a murine S. aureus sepsis model. Infect. Immun. 74:2215-2223. http://dx.doi.org/10.1128/IAI.74.4.2215-2223.2006
45. Landrum, M.L., C. Neumann, C. Cook, U. Chukwuma, M.W. Ellis, D.R. Hospenthal, and C.K. Murray. 2012. Epidemiology of Staphylococcus aureus blood and skin and soft tissue infections in the US military health system, 2005-2010. JAMA. 308:50-59. http://dx.doi.org/10.1001/jama.2012.7139
46. Lin, F.Y., V.A. Ho, H.B. Khiem, D.D. Trach, P.V. Bay, T.C. Thanh, Z. Kossaczka, D.A. Bryla, J. Shiloach, J.B. Robbins, et al. 2001. The efficacy of a Salmonella typhi Vi conjugate vaccine in two-to-five-year-old children. N. Engl. J. Med. 344:1263-1269. http://dx.doi.org/10.1056/NEJM200104263441701
47. Lindsay, J.A. 2014. Staphylococcus aureus genomics and the impact of horizontal gene transfer. Int. J. Med. Microbiol. 304:103-109. http://dx.doi.org/10.1016/j.ijmm.2013.11.010
48. Lowy, F.D. 1998. Staphylococcus aureus infections. N. Engl. J. Med. 339:520-532. http://dx.doi.org/10.1056/NEJM199808203390806
49. Matsuhashi, M., M.D. Song, F. Ishino, M. Wachi, M. Doi, M. Inoue, K. Ubukata, N. Yamashita, and M. Konno. 1986. Molecular cloning of the gene of a penicillin-binding protein supposed to cause high resistance to β-lactam antibiotics in Staphylococcus aureus. J. Bacteriol. 167:975-980.
50. Mazmanian, S.K., E.P. Skaar, A.H. Gaspar, M. Humayun, P. Gornicki, J. Jelenska, A. Joachmiak, D.M. Missiakas, and O. Schneewind. 2003. Passage of heme-iron across the envelope of Staphylococcus aureus. Science. 299:906-909. http://dx.doi.org/10.1126/science.1081147
51. McAdow, M., H.K. Kim, A.C. Dedent, A.P.A. Hendrickx, O. Schneewind, and D.M. Missiakas. 2011. Preventing Staphylococcus aureus sepsis through the inhibition of its agglutination in blood. PLoS Pathog. 7:e1002307. http://dx.doi.org/10.1371/journal.ppat.1002307
52. McAdow, M., A.C. DeDent, C. Emolo, A.G. Cheng, B.N. Kreiswirth, D.M. Missiakas, and O. Schneewind. 2012a. Coagulases as determinants of protective immune responses against Staphylococcus aureus. Infect. Immun. 80:3389-3398. http://dx.doi.org/10.1128/IAI.00562-12
53. McAdow, M., D.M. Missiakas, and O. Schneewind. 2012b. Staphylococcus aureus secretes coagulase and von Willebrand factor binding protein to modify the coagulation cascade and establish host infections. J. Innate Immun. 4:141-148. http://dx.doi.org/10.1159/000333447
54. McCarthy, A.J., and J.A. Lindsay. 2010. Genetic variation in Staphylococcus aureus surface and immune evasion genes is lineage associated: implications for vaccine design and host-pathogen interactions. BMC Microbiol. 10:173. http://dx.doi.org/10.1186/1471-2180-10-173
55. Pasteur, L. 1881. De l'atténuation des virus et de leur retour à la virulence. Comptes rendus de l'Académie des Sciences. 92:429-435.
56. Pauli, N.T., H.K. Kim, F. Falugi, M. Huang, J. Dulac, C. Henry Dunand, N.Y. Zheng, K. Kaur, S.F. Andrews, Y. Huang, et al. 2014. Staphylococcus aureus infection induces protein A-mediated immune evasion in humans. J. Exp. Med. 211:2331-2339. http://dx.doi.org/10.1084/jem.20141404
57. Pelz, A., K.P. Wieland, K. Putzbach, P. Hentschel, K. Albert, and F. Götz. 2005. Structure and biosynthesis of staphyloxanthin from Staphylococcus aureus. J. Biol. Chem. 280:32493-32498. http://dx.doi.org/10.1074/jbc.M505070200
58. Peters, P.J., J.T. Brooks, S.K. McAllister, B. Limbago, H.K. Lowery, G. Fosheim, J.L. Guest, R.J. Gorwitz, M. Bethea, J. Hageman, et al. 2013. Methicillinresistant Staphylococcus aureus colonization of the groin and risk for clinical infection among HIV-infected adults. Emerg. Infect. Dis. 19:623-629. http://dx.doi.org/10.3201/eid1904.121353
59. Plotkin, S.A. 2008. Vaccines: correlates of vaccine-induced immunity. Clin. Infect. Dis. 47:401-409. http://dx.doi.org/10.1086/589862
60. Pollard, A.J., K.P. Perrett, and P.C. Beverley. 2009. Maintaining protection against invasive bacteria with protein-polysaccharide conjugate vaccines. Nat. Rev. Immunol. 9:213-220. http://dx.doi.org/10.1038/nri2494
61. Rogers, D.E., and M.A. Melly. 1965. Speculations on the immunology of staphylococcal infections. Ann. N. Y. Acad. Sci. 128:274-284. http://dx.doi.org/10.1111/j.1749-6632.1965.tb11644.x
62. Schneerson, R., O. Barrera, A. Sutton, and J.B. Robbins. 1980. Preparation, characterization, and immunogenicity of Haemophilus influenzae type b polysaccharide-protein conjugates. J. Exp. Med. 152:361-376. http://dx.doi.org/10.1084/jem.152.2.361
63. Schuster, J.M., G. Rechtine, D.C. Norvell, and J.R. Dettori. 2010. The influence of perioperative risk factors and therapeutic interventions on infection rates after spine surgery: a systematic review. Spine. 35:S125-S137. http://dx.doi.org/10.1097/BRS.0b013e3181d8342c
64. Scully, I.L., P.A. Liberator, K.U. Jansen, and A.S. Anderson. 2014. Covering all the bases: preclinical development of an effective Staphylococcus aureus vaccine. Front. Immunol. 5:109. http://dx.doi.org/10.3389/fimmu.2014.00109
65. Shinefield, H.R., and S. Black. 2005. Prevention of Staphylococcus aureus infections: advances in vaccine development. Expert Rev. Vaccines. 4:669-676. http://dx.doi.org/10.1586/14760584.4.5.669
66. Shinefield, H., S. Black, A. Fattom, G. Horwith, S. Rasgon, J. Ordonez, H. Yeoh, D. Law, J.B. Robbins, R. Schneerson, et al. 2002. Use of a Staphylococcus aureus conjugate vaccine in patients receiving hemodialysis. N. Engl. J. Med. 346:491-496. http://dx.doi.org/10.1056/NEJMoa011297
67. Shopsin, B., M. Gomez, S.O. Montgomery, D.H. Smith, M. Waddington, D.E. Dodge, D.A. Bost, M. Riehman, S. Naidich, and B.N. Kreiswirth. 1999. Evaluation of protein A gene polymorphic region DNA sequencing for typing of Staphylococcus aureus strains. J. Clin. Microbiol. 37:3556-3563.
68. Silverman, G.J., and C.S. Goodyear. 2006. Confounding B-cell defences: lessons from a staphylococcal superantigen. Nat. Rev. Immunol. 6:465-475. http://dx.doi.org/10.1038/nri1853
69. Spellberg, B., and R. Daum. 2012. Development of a vaccine against Staphylococcus aureus. Semin. Immunopathol. 34:335-348. http://dx.doi.org/10.1007/s00281-011-0293-5
70. Sterne, M. 1946. Avirulent anthrax vaccine. Onderstepoort J. Vet. Sci. Anim. Ind.21:41-43.
71. Suaya, J.A., R.M. Mera, A. Cassidy, P. O'Hara, H. Amrine-Madsen, S. Burstin, and L.G. Miller. 2014. Incidence and cost of hospitalizations associated with Staphylococcus aureus skin and soft tissue infections in the United States from 2001 through 2009. BMC Infect. Dis. 14:296. http://dx.doi.org/10.1186/1471-2334-14-296
72. Swierstra, J., S. Debets, C. de Vogel, N. Lemmens-den Toom, N. Verkaik, N. Ramdani-Bouguessa, M.F. Jonkman, J.M. van Dijl, A. Fahal, A. van Belkum, and W. van Wamel. 2015. IgG4 subclass-specific responses to Staphylococcus aureus antigens shed new light on host-pathogen interaction. Infect. Immun. 83:492-501. http://dx.doi.org/10.1128/IAI.02286-14
73. Thammavongsa, V., H.K. Kim, D. Missiakas, and O. Schneewind. 2015a. Staphylococcal manipulation of host immune responses. Nat. Rev. Microbiol. 13:529-543. http://dx.doi.org/10.1038/nrmicro3521
74. Thammavongsa, V., S. Rauch, H.K. Kim, D.M. Missiakas, and O. Schneewind. 2015b. Protein A-neutralizing monoclonal antibody protects neonatal mice against Staphylococcus aureus. Vaccine. 33:523-526. http://dx.doi.org/10.1016/j.vaccine.2014.11.051
75. Thomer, L., C. Emolo, V. Thammavongsa, H.K. Kim, M.E. McAdow, W. Yu, M. Kieffer, O. Schneewind, and D. Missiakas. 2016. Antibodies against a secreted product of Staphylococcus aureus trigger phagocytic killing. J. Exp. Med. 213:293-301. http://dx.doi.org/10.1084/jem.20150074
76. Torres, V.J., G. Pishchany, M. Humayun, O. Schneewind, and E.P. Skaar. 2006. Staphylococcus aureus IsdB is a hemoglobin receptor required for heme iron utilization. J. Bacteriol. 188:8421-8429. http://dx.doi.org/10.1128/JB.01335-06
77. Verkaik, N.J., A. Lebon, C.P. de Vogel, H. Hooijkaas, H.A. Verbrugh, V.W. Jaddoe, A. Hofman, H.A. Moll, A. van Belkum, and W.J. van Wamel. 2010. Induction of antibodies by Staphylococcus aureus nasal colonization in young children. Clin. Microbiol. Infect. 16:1312-1317. http://dx.doi.org/10.1111/j.1469-0691.2009.03073.x
78. Viana, D., J. Blanco, M.A. Tormo-Más, L. Selva, C.M. Guinane, R. Baselga, J. Corpa, I. Lasa, R.P. Novick, J.R. Fitzgerald, and J.R. Penadés. 2010. Adaptation of Staphylococcus aureus to ruminant and equine hosts involves SaPI-carried variants of von Willebrand factor-binding protein. Mol. Microbiol. 77:1583-1594. http://dx.doi.org/10.1111/j.1365-2958.2010.07312.x
79. Votintseva, A.A., R. Fung, R.R. Miller, K. Knox, H. Godwin, D.H. Wyllie, R. Bowden, D.W. Crook, and A.S. Walker. 2014. Prevalence of Staphylococcus aureus protein A (spa) mutants in the community and hospitals in Oxfordshire. BMC Microbiol. 14:63. http://dx.doi.org/10.1186/1471-2180-14-63
80. Watanabe, S., T. Ito, T. Sasaki, S. Li, I. Uchiyama, K. Kishii, K. Kikuchi, R.L. Skov, and K. Hiramatsu. 2009. Genetic diversity of staphylocoagulase genes (coa): insight into the evolution of variable chromosomal virulence factors in Staphylococcus aureus. PLoS One. 4:e5714. http://dx.doi.org/10.1371/journal.pone.0005714
81. Wertheim, H.F., D.C. Melles, M.C. Vos, W. van Leeuwen, A. van Belkum, H.A. Verbrugh, and J.L. Nouwen. 2005. The role of nasal carriage in Staphylococcus aureus infections. Lancet Infect. Dis. 5:751-762. http://dx.doi.org/10.1016/S1473-3099(05)70295-4